Member Info for Trickymatters

Never been a deramper or a troll Expert. Never will be. Respect for all investors is my mantra.
Interested in cold hard facts. All good for GDR. EU CE-IVD mark means that this time they can sell across the EU. High performance product on a par with PCR. 98-100% accuracy meets or exceeds all major regulatory standards here and across the world. If they don't price it too high it could become the default model for PCR. First mover advantage. They got this right so far. Approved 10 days after final data submission. Suggests there will be strong demand. Unsurprisingly. Mobile, faster than an lft with the accuracy of a PCR. Picks up all variants. Facts look good to me.

Expert, ain't all about you mate. You were telling people to buy high. So you are coming over as a player.
Plenty of buying. 3:2 buys to sells. Suspect that mms are tipping out the iis who got in at placement. They will still have a good return. Then we will have to move up.

Focus on why you're in. Don't bother taking on every 2 bit troll. Makes the board quite hard to read. You can filter the plonkers if you want too. I have filtered the worst. Less stressful.

https://www.fdanews.com/articles/205806-genedrive-gets-ce-ivd-mark-for-its-genedrivecov19-id-kit?s=09
Check this out. The site is for pharma industry professionals and executives.

Probably a good idea not to engage with the trolls. They are: Jaceorge; allah4uk; Pennystockgrowth (trader changes their mind depending on their meds); davemcmanus...you know the rest.

What have we got to look forward to?
1. A solid sales and distribution agreement with an approved test with big pharma companies. The multi billion pound valued Beckman Coulter and Germany's medium sized juggernaut Sysmex are likely to be in the mix.
2. Inclusion on the EU Common list on the next update after the sales agreement is in place.
3. Orders for this portable device and tests from governments, businesses of all kinds and health care settings. It will save time. It could become a displacement product for PCR. Just as accurate. Picks up all variants. Much cheaper than PCR.
4. An investment presentation will clarify the margins. Likely to be looking at £8-10 a test for GDR. The PCR kit agreement with BC was for £10 a test. And another higher return for every processing device sold.

Shortages of PCR tests according to the Telegraph.

www.gov.uk covid19 test approval- step 2: process for desk top review
Will be tweeting on this. Check out the site. It is an essential requirement to have an EU CE-IVD mark or MHRA derogation from the UK to get a UK CTA permission to sell. Budd delivered this inside 2 weeks as promised. Inclusion on the common list means GDR can sell across the EU now. This is one step up from just getting approved by one EU nation.
A new list of rejected tests is out now. Updated December 1st. We can't see who the providers are of course. Probably read about it in the Times in 2 months time.
GDR are the safe bet. They easily exceed minimum requirements for 90% sensitivity at 98%. Next RNS will be a sales distribution agreement and the sp will open 10p up. Traders are reducing their opportunity jumping between British diagnostics.
The fact that GDR's poc test has been approved so quickly bodes very well. The test is wanted at this time of the new threat from Omnicrum.
Buy now or cry later.

Good saying hey? We've got EU approval. Everyone else is still waiting. GLA!

We didn't get EU wide approval last time Pennystockgrowth. We only had approval in one small EU country. This is very different. Approval across the EU. Huge credibility.

Wantmeahouse, lol! You go girl!

And we're opening at 90p. Then over £1 in minutes. Then all the hot money and a few more iis are coming in here. But £10 sp? Umm. Maybe sell at £2.50 to be on the safe side. ;)

Hey Inphobe, how's it going? Can you recall what kind of margins they are expecting for this test? I know you know your stuff.

Good list of investors. Plenty of iis.

Who are the top 10 shareholders then?

Budd agreed £10 a test for GDR on the PCR test with Beckman Coulter. Does anyone have the estimated price that GDR will sell the poc for? Might help for investors to get an idea of the turnover and margins on this product. I think it will be very popular. Convenient for big business and airlines especially. It's their IP so they should get a great return. Certainly transformational for this small company.

Fairly obvious a lot of people are buying ODX with GDR profits. Mologic's test has been approved. ODX could benefit. But their test is still under evaluation. GDR will burst first. Mistake to move imo. No need to sit and stare at the sp and stress yourself to bits. Another RNS is due here anytime. It will detail the commercial agreement with pharmaceutical companies. Budd will promote it. Dumb to trade. You will miss out big time if the RNS lands.

My guess for sp at close of play gone already! Lol. I know nothing! Whoop Whoop.

Buying is pretty relentless atm. Revising my guess for sp at close today. 69p. Open 72 tomoz.

My guess is close at 66p today. Open 70p tomoz. 99p-£1.60 on commercial deals RNSes. All short term.